Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT04183257

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04183257
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04183257. Randomized; no masking; primary purpose treatment. Start 2016-09-30 (actual); primary completion 2017-04-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
Condition
Vitamin D Deficiency
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
oral vitamin D
Lead sponsor
King Edward Medical University (class: other)

Record details

Record id
cardio:ct-nct04183257
Content hash
a04feaddc3eed653f9c7335dc45a3f6592410856289c87ca0434dc2ab60f2331